ADRX insider trading — ADARx Pharmaceuticals, Inc.
Over the last 90 days, insiders at ADARx Pharmaceuticals, Inc. (ADRX) made 2 open-market purchases worth $43.35M and 0 open-market sales worth $0, making them net buyers by $43.35M. The largest purchase was by George Simeon (Director), who bought 1,600,000 shares for $27.20M on Sep 28, 2026. 2 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Oct 16, 2026.
Recent ADRX insider transactions
Every Form 4 filed by ADARx Pharmaceuticals, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Chimovits Erez | Director | C · Conversion | Indirect | 9,230,509 | — | — | Form 4 |
| Sep 28, 2026 | Chimovits Erez | Director | P · Purchase | Indirect | 61,516 | $17.00 | $1.05M | Form 4 |
| Sep 28, 2026 | Gordon Carl L | Director | C · Conversion | Indirect | 23,255,789 | — | — | Form 4 |
| Sep 28, 2026 | Gordon Carl L | Director | P · Purchase | Indirect | 950,000 | $17.00 | $16.15M | Form 4 |
| Sep 28, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Vii Llc, Orbimed Israel Gp Ii, L.P., Orbimed Advisors Israel Ii Ltd, Orbimed Genesis Gp Llc | Director | C · Conversion | Indirect | 23,255,789 | — | — | Form 4 |
| Sep 28, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Vii Llc, Orbimed Israel Gp Ii, L.P., Orbimed Advisors Israel Ii Ltd, Orbimed Genesis Gp Llc | Director | P · Purchase | Indirect | 950,000 | $17.00 | $16.15M | Form 4 |
| Sep 28, 2026 | Sr One Capital Management, Llc | 10% Owner | C · Conversion | Indirect | 8,336,661 | — | — | Form 4 |
| Sep 28, 2026 | Sr One Capital Management, Llc | 10% Owner | P · Purchase | Indirect | 1,600,000 | $17.00 | $27.20M | Form 4 |
| Sep 28, 2026 | George Simeon | Director | C · Conversion | Indirect | 8,336,661 | — | — | Form 4 |
| Sep 28, 2026 | George Simeon | Director | P · Purchase | Indirect | 1,600,000 | $17.00 | $27.20M | Form 4 |
| Sep 28, 2026 | Lav Biosciences Fund V, L.P., Lav Fund Vi Opportunities, L.P., Lav Fund Vi, L.P. | 10% Owner | C · Conversion | Direct | 11,243,179 | — | — | Form 4 |
| Sep 28, 2026 | Lav Biosciences Fund V, L.P., Lav Fund Vi Opportunities, L.P., Lav Fund Vi, L.P. | 10% Owner | C · Conversion | Indirect | 615,476 | — | — | Form 4 |
ADRX insider trading FAQ
Are insiders buying ADRX stock?
Yes. In the last 90 days, ADARx Pharmaceuticals, Inc. insiders made 2 open-market purchases totaling $43.35M, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ADRX?
Recent buyers: George Simeon, Gordon Carl L.
Where does ADRX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.